Family Medicine · Burbank, CA
NPI
1043415383
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
4323 W Riverside Dr
Burbank, CA, 91505
Phone (818) 556-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
865 services
Medicare patients, 2024
467
Average age 71
Drug cost, 2024
$147K
2,229 prescriptions
Company payments, 2025
$559
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana Dermendjian was code 99214 (office e&m - established), 347 times for 293 patients. In total Diana Dermendjian billed 865 services in 33 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 347 | 293 | $78.87 | $27K |
| 99213 Office E&M - Established | Office | 225 | 188 | $57.79 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 49 | 36 | $11.72 | $574 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 46 | 46 | $71.03 | $3,267 |
| 99215 Office E&M - Established | Office | 26 | 22 | $59.46 | $1,546 |
| G0009 Administration of pneumococcal vaccine | Office | 17 | 17 | $35.02 | $595 |
| 90677 Vaccine Product | Office | 17 | 17 | $288.84 | $4,910 |
| 93000 Electrocardiogram | Office | 16 | 13 | $11.63 | $186 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 16 | $32.83 | $525 |
| 90662 Vaccine Product | Office | 14 | 14 | $74.56 | $1,044 |
| 90480 Vaccine Administration | Office | 12 | 11 | $42.80 | $514 |
| 91320 Vaccine Product | Office | 12 | 11 | $127.90 | $1,535 |
By year: 2022 $17K for 284 services; 2023 $31K for 499 services; 2024 $58K for 865 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 16 | $2.94 | $47.1 |
Medicare prescription drug claims, 2024
In 2024, the drug Diana Dermendjian prescribed most often to Medicare patients was Fluticasone Propionate, with 116 prescriptions and refills. In total Diana Dermendjian wrote 2,229 Medicare prescriptions that cost $147K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 116 | 278 | 91 | $860 |
| Paxlovid Nirmatrelvir/Ritonavir | 113 | 113 | 113 | $52K |
| Atorvastatin Calcium Generic | 94 | 271 | 40 | $1,360 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 83 | 83 | 76 | $758 |
| Losartan Potassium Generic | 82 | 204 | 33 | $933 |
| Amlodipine Besylate Generic | 79 | 211 | 25 | $815 |
| Rosuvastatin Calcium Generic | 77 | 217 | 33 | $1,737 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 75 | 78 | 60 | $1,352 |
| Levothyroxine Sodium Generic | 50 | 150 | 20 | $568 |
| Metoprolol Succinate Generic | 49 | 117 | 18 | $1,049 |
| Omeprazole Generic | 47 | 97 | 20 | $607 |
| Lisinopril Generic | 44 | 129 | 18 | $401 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 44 | 44 | 39 | $147 |
| Trazodone Hcl Generic | 44 | 102 | 24 | $635 |
| Methylprednisolone Generic | 40 | 40 | 35 | $243 |
Brand drugs: 278 claims; generic drugs: 1,923 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana Dermendjian $559 ($559 in general payments such as food, travel and fees) from 6 companies. The largest payer was Phathom Pharmaceuticals, Inc. with $126.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.